To study the ability of antisense oligonucleotides to induce readthrough of premature stop codons, we first developed a reporter mRNA in which translation of nanoluciferase requires the readthrough of the CFTR G542X mutation, the most frequent nonsense mutation in cystic fibrosis patients (Figure 1A). This evidence concerns the gene CFTR and cystic fibrosis.